Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $41.29 Average Price Target from Brokerages
Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]
Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]
